# INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

> **NCT00472771** · PHASE2 · WITHDRAWN · sponsor: **CytRx**

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** INNO-206

## Key facts

- **NCT ID:** NCT00472771
- **Lead sponsor:** CytRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-05
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated due to clinical trial material production delays
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472771, "INNO-206 in Patients With Small Cell Lung Cancer (SCLC)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00472771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*